ctrl K

Watchlist Price Alert

CERo Therapeutics Inc. (CERO)

NASDAQ: CERO · Real-Time Price · USD

20.08

13.21 (192.37%)

At close: Jun 17, 2025, 3:59 PM

CERo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-15.3M	-2.93M	-2.91M	-332.03K
Interest Income	n/a	491.57K	142.12K	986.71K
Pretax Income	-7.73M	-2.44M	-68.58K	-332.42K
Net Income	-7.73M	-2.54K	-667.74K	-315.55K
Selling & General & Admin	8.98M	2.89M	2.84M	251.71K
Research & Development	6.32M	n/a	9.85M	9.14M
Other Expenses	n/a	40.05K	-64.05K	-80.32K
Operating Expenses	15.3M	2.93M	2.91M	332.03K
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	2.89M	715.76K	-2.23M
Cost & Expenses	15.3M	2.93M	2.91M	332.03K
Income Tax Expense	n/a	94.82K	599.16K	-16.87K
Shares Outstanding (Basic)	579.43K	19.58M	20.31M	22.98M
Shares Outstanding (Diluted)	579.43K	19.59M	20.31M	22.98M
EPS (Basic)	-18.15	-0.00	-0.03	-0.01
EPS (Diluted)	-18.15	-0.00	-0.03	-0.01
EBITDA	-6.57M	-2.44M	-68.58K	-332.03K
EBIT	-7.73M	-2.44M	-2.91M	-332.42K
Depreciation & Amortization	1.16M	2.93K	1.07M	735.47K